Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum
Baird Medical (NASDAQ: BDMD) participated in and supported the 2024 Guangdong Provincial Parathyroid Disease - Southern Yue Forum in Guangzhou, China. The company, specializing in minimally invasive microwave ablation (MWA) technology, showcased its innovations in endocrine care at the event.
The forum brought together medical experts, researchers, and healthcare professionals to discuss advancements in parathyroid disease diagnosis and treatment. As a sponsor, Baird Medical presented its MWA technology designed for endocrine conditions, engaging with key opinion leaders and fostering collaborations to better understand clinical needs.
Baird Medical (NASDAQ: BDMD) ha partecipato e sostenuto il Forum del 2024 sulle malattie paratiroidee della Provincia del Guangdong - Southern Yue a Guangzhou, in Cina. L'azienda, specializzata nella tecnologia di ablazione a microonde minimamente invasiva (MWA), ha presentato le sue innovazioni nella cura endocrina durante l'evento.
Il forum ha riunito esperti medici, ricercatori e professionisti della salute per discutere i progressi nella diagnosi e nel trattamento delle malattie paratiroidee. In quanto sponsor, Baird Medical ha presentato la sua tecnologia MWA progettata per le condizioni endocrine, interagendo con leader d'opinione chiave e promuovendo collaborazioni per comprendere meglio le esigenze cliniche.
Baird Medical (NASDAQ: BDMD) participó y apoyó el Foro de Enfermedades Paratiroides de la Provincia de Guangdong 2024 - Southern Yue en Guangzhou, China. La empresa, especializada en tecnología de ablación por microondas mínimamente invasiva (MWA), presentó sus innovaciones en el cuidado endocrino durante el evento.
El foro reunió a expertos médicos, investigadores y profesionales de la salud para discutir los avances en el diagnóstico y tratamiento de las enfermedades paratiroides. Como patrocinador, Baird Medical presentó su tecnología MWA diseñada para condiciones endocrinas, involucrándose con líderes de opinión clave y fomentando colaboraciones para entender mejor las necesidades clínicas.
Baird Medical (NASDAQ: BDMD)는 중국 광저우에서 열린 2024 광둥성 부갑상선 질환 - Southern Yue 포럼에 참여하고 지원했습니다. 이 회사는 최소 침습적 마이크로웨이브 절제술(MWA) 기술에 특화되어 있으며, 행사에서 내분비학 치료의 혁신을 선보였습니다.
이번 포럼은 의료 전문가, 연구원 및 건강 전문가들이 모여 부갑상선 질환의 진단 및 치료에서의 발전에 대해 논의하는 자리였습니다. Baird Medical은 후원사로서 내분비 조건을 위해 설계된 MWA 기술을 발표하며, 주요 의견 지도자들과 교류하고 임상 요구 사항을 더 잘 이해하기 위한 협업을 촉진했습니다.
Baird Medical (NASDAQ: BDMD) a participé et soutenu le Forum 2024 sur les maladies parathyroïdiennes de la province du Guangdong - Southern Yue à Guangzhou, en Chine. L'entreprise, spécialisée dans la technologie d'ablation par micro-ondes peu invasive (MWA), a présenté ses innovations en matière de soins endocriniens lors de l'événement.
Le forum a rassemblé des experts médicaux, des chercheurs et des professionnels de la santé pour discuter des avancées dans le diagnostic et le traitement des maladies parathyroïdiennes. En tant que sponsor, Baird Medical a présenté sa technologie MWA conçue pour les conditions endocrines, interagissant avec des leaders d'opinion clés et favorisant des collaborations afin de mieux comprendre les besoins cliniques.
Baird Medical (NASDAQ: BDMD) nahm am Forum für Nebenschilddrüsenerkrankungen der Provinz Guangdong 2024 - Southern Yue in Guangzhou, China, teil und unterstützte es. Das Unternehmen, das sich auf minimalinvasive Mikrowellenablation (MWA) Technologie spezialisiert hat, stellte während der Veranstaltung seine Innovationen in der endokrinen Versorgung vor.
Das Forum brachte medizinische Experten, Forscher und Fachleute im Gesundheitswesen zusammen, um über Fortschritte bei der Diagnose und Behandlung von Nebenschilddrüsenerkrankungen zu diskutieren. Als Sponsor präsentierte Baird Medical seine MWA-Technologie, die für endokrine Erkrankungen entwickelt wurde, und engagierte sich mit wichtigen Meinungsführern, um die klinischen Bedürfnisse besser zu verstehen und Kooperationen zu fördern.
- None.
- None.
This distinguished forum, organized by prominent healthcare institutions in
As a sponsor, Baird Medical presented its cutting-edge microwave ablation technology, designed to deliver precise and efficient treatment options for endocrine conditions, including parathyroid diseases. Participants had the opportunity to learn about the company's approach to minimally invasive therapies, aimed at optimizing patient outcomes.
"We are pleased to participate in this highly regarded forum, which reflects our ongoing commitment to supporting medical advancements in endocrine disease management," said Haimei Wu, Chairwoman of Baird Medical. "Our focus remains on empowering medical professionals with innovative solutions that contribute to improved patient care and clinical outcomes."
The forum provided Baird Medical with the opportunity to engage with key opinion leaders, foster collaborations, and deepen its understanding of evolving clinical needs. The company's participation underscores its commitment to advancing minimally invasive medical technologies and contributing to the broader healthcare community in a responsible and impactful manner.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.
These forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results or outcomes to differ materially from those expressed or implied. These statements are based on estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. Risks and uncertainties may emerge over time, and it is not possible to anticipate all potential factors that could affect Baird Medical's business and financial performance.
Factors that could cause actual results to differ materially include, but are not limited to: (1) the risk that Baird Medical may not achieve its expansion goals in
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Baird Medical undertakes no obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-showcases-innovations-in-endocrine-care-at-2024-southern-yue-forum-302340100.html
SOURCE BDMD
FAQ
What technology did Baird Medical (BDMD) showcase at the 2024 Southern Yue Forum?
Where and when did Baird Medical (BDMD) present its endocrine care innovations?
What was the purpose of BDMD's participation in the 2024 Southern Yue Forum?
What medical conditions does Baird Medical's (BDMD) MWA technology target?
